Several other companies, both domestic and foreign, are working to
develop alternatives to human blood. They include: Alliance Pharmaceutical
Corporation (San Diego, California); Baxter International (Deerfield,
Illinois); Biopure Corporation (Boston, Massachusetts); Northfield Labs
(Chicago, Illinois); and Somatogen Corporation (Boulder, Colorado). These
competitors are involved in the development of a wide variety of human
blood substitutes, including synthetic compounds, recycled human blood and
recombinant hemoglobin. Neither the list of competitors nor the list of human
blood substitutes is exhaustive. Furthermore, many of the Company's existing
or potential competitors have significantly greater technical and financial
resources than the Company and may be better able to develop, test, produce
and market products. These competitors may develop products that are
competitive with or better than the Company's product and that may render the
Company's product obsolete. The Company can provide no assurance that it will
be able to compete successfully. |
